Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference
Jennifer L. McKimm‐Breschkin, Alan Hay, Bin Cao, et al.
Antiviral Research (2021) Vol. 197, pp. 105227-105227
Open Access | Times Cited: 24

Showing 24 citing articles:

A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part
Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 10
Open Access | Times Cited: 105
COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature
Helena C. Maltezou, Amalia Papanikolopoulou, Sofia Vassiliu, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 865-865
Open Access | Times Cited: 53
First-generation oral antivirals against SARS-CoV-2
Parham Sendi, Raymund R. Razonable, Sandra B. Nelson, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 9, pp. 1230-1235
Open Access | Times Cited: 32
Absenteeism of Healthcare Personnel in the COVID-19 Era: A Systematic Review of the Literature and Implications for the Post-Pandemic Seasons
Helena C. Maltezou, Caterina Ledda, Nikolaos V. Sipsas
Healthcare (2023) Vol. 11, Iss. 22, pp. 2950-2950
Open Access | Times Cited: 15
Targeting host-virus interactions: in silico analysis of the binding of human milk oligosaccharides to viral proteins involved in respiratory infections
Anees Ahmed Mahaboob Ali, Adarsh Vishal, Everette Jacob Remington Nelson
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Ensitrelvir as a potential treatment for COVID-19
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 18, pp. 1995-1998
Closed Access | Times Cited: 17
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Yiying Xue, Husheng Mei, Yisa Chen, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 11
Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 Mpro
Jiayi Ren, Zhengfu Zhang, Yi Xia, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 351-351
Open Access
Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions
Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Awareness, knowledge and attitude toward influenza vaccination in several population groups in China: A cross-sectional study
Binshan Jiang, Zhenzhong Wang, Mengmeng Jia, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 10
Resurgence of Respiratory Syncytial Virus in Children: An Out-of-Season Epidemic in Portugal
Ana Rita Torres, Raquel Guiomar Guiomar, Nuno Verdasca, et al.
Acta Médica Portuguesa (2023)
Open Access | Times Cited: 5
Therapeutic efficacy of antibodies and antivirals against a SARS-CoV-2 Omicron variant
Ryuta Uraki, Maki Kiso, Masaki Imai, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 7
Respiratory syncytial virus under 2 years of age: hospitalization trends and risk factors for severe disease Ó? preliminary data from the Portuguese sentinel network
Ana Rita Torres, Aryse Martins Melo, Carlos Aniceto, et al.
Portuguese Journal of Pediatrics (2024) Vol. 55, Iss. 1
Open Access | Times Cited: 1
Characterization of SARS-COV-2 main protease inhibitory peptides from Ulva prolifera proteins
Zhiyong Li, Yehua Wang, Caiwei Fu, et al.
Journal of Oceanology and Limnology (2023) Vol. 41, Iss. 5, pp. 1887-1899
Closed Access | Times Cited: 3
Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study
Xiaodan Guo, Yihua Lin, Fengming He, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 8, pp. 871-889
Closed Access | Times Cited: 3
Using CONTAM to design ventilation strategy of negative pressure isolation ward considering different height of door gaps
Mingyao Ma, Changsheng Cao, Yukun Xu, et al.
Energy and Built Environment (2022) Vol. 5, Iss. 1, pp. 32-45
Open Access | Times Cited: 5
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-like Protease Inhibitor, in Japanese Patients With Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part
Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Neddylation tunes peripheral blood mononuclear cells immune response in COVID-19 patients
Marina Serrano‐Maciá, Sofía Lachiondo‐Ortega, Paula Iruzubieta, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Two-stage one-pot synthetic strategy for the key triazone-triazole intermediate of ensitrelvir (S-217622), an oral clinical candidate for treating COVID-19
Wei Hu, Xiang Zhang, Yuanchang Liu, et al.
RSC Advances (2022) Vol. 12, Iss. 54, pp. 34808-34814
Open Access | Times Cited: 3
Small change for big improvement in the preparation of the key intermediate N1, N3-disubstituted 1,3,5-triazone of ensitrelvir
Wei Hu, Yuanchang Liu, Xiang Zhang, et al.
RSC Advances (2023) Vol. 13, Iss. 6, pp. 3688-3693
Open Access | Times Cited: 1
Development of a cell-based DIFF-rGFP assay system for generalized discovery of viral protease Inhibitors
Xiaoyan Wu, Feng Yan, Rui-ting Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Managing uncertainty and complexity during a public health emergency: Understanding the immediate and ongoing effects of the COVID-19 epidemic on a global Neglected Tropical Disease program
Elizabeth Sutherland, Rafaël Stelmach, Nicola Warren, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Journalists' understanding of COVID-19 coverage in Medan, Indonesia
Muhammad thariq .
Deleted Journal (2024) Vol. 8, Iss. 3, pp. 655-664
Open Access
Respiratory syncytial virus: burden, risks, and the way forward—calling for a collaborative approach at World Prematurity Day 2022
Christina Tischer, Johanna Kostenzer, Silke Mader, et al.
AJP Lung Cellular and Molecular Physiology (2022) Vol. 323, Iss. 5, pp. L619-L622
Closed Access | Times Cited: 2
Page 1

Scroll to top